Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Clinical trial NCT01900665 · TERMINATED
Trial details
- NCT number
- NCT01900665
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2016-10-01
- Enrollment
- 2129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.